@article{ETD,
      recid = {355},
      author = {Feifers, Julie},
      title = {Omega-3 fatty acids, inflammation, and outcome in men with  and without prostate cancer},
      publisher = {Oregon Health and Science University},
      school = {M.S.},
      address = {2009},
      number = {ETD},
      abstract = {Chronic inflammation may contribute to prostate cancer  development and progression, with elevated interleukin‑6  (IL‑6) and C‑reactive protein (CRP) associated with poorer  outcomes. Omega‑3 (n‑3) fatty acids, known for  anti‑inflammatory effects, may reduce prostate cancer risk  by lowering these markers. This secondary analysis examined  relationships among inflammation, prostate cancer status,  and n‑3 fatty acid levels using data from a case‑control  study. Plasma IL‑6 and CRP were measured in prostate cancer  cases (n=121) and biopsy‑negative controls (n=240), and  erythrocyte EPA and DHA were quantified via gas  chromatography–mass spectrometry. This study aimed to  evaluate inflammatory profiles and the potential modifying  role of n‑3 fatty acids in prostate cancer.},
      url = {http://digitalcollections.ohsu.edu/record/355},
      doi = {https://doi.org/10.6083/M40C4SQ2},
}